16th September 2021
TRANSBRONCHIAL CRYOBIOPSY IN DIFFUSE PARENCHYMAL LUNG DISEASE
08.15 - 08.30
TRANSBRONCHIAL CRYOBIOPSY IN DIFFUSE PARENCHYMAL LUNG DISEASE
Welcome and Introduction
08.30 - 10.00
I SESSION: Basic Science Corner/Connections
Chairperson: K. Antoniou, M. Bonifazi
Mithocondria and other stuff: their role in ILDs
COVID-19 interstitial pneumonia and fibrosing ILDs
Molecular analysis on small samples for UIP diagnosis
10.00 - 14.30
II SESSION: Clinical views I
Chairperson: S. Gasparini
CT: the lessons from COVID-19
Lung cancer and IPF
Clinical features of progressive fibrosing ILDs
Autoinflammatory disorders
14.30 - 16.00
III SESSION: Technical Corner I
Chairperson: L. Zuccatosta
1 - Cryosurgery: physics and applications
2 - Transbronchial cryobiopsy: the techniques
Robotic bronchoscopy
16.00 - 17.00
IV SESSION Technical Corner II
Chairperson: S. Puglisi
Guiding systems for TBCB
17th September 2021
TRANSBRONCHIAL CRYOBIOPSY IN DIFFUSE PARENCHYMAL LUNG DISEASE
08.00 - 11.00
V SESSION: Clinical views II
Chairperson: A. U. Wells
The role of immunohistochemistry and molecular biology on cryobiopsy samples
Pathologic identification of UIP/Chronic HP/NSIP on TBLC
What makes a good multidisciplinary discussion?
TBLCB: diagnostic accuracy
TBLCB: prognostic impact
11.00 - 12.00
VI SESSION: TBLCB in specific settings
Chairperson: M. Bezzi
TBLCB in ICU
Lecture: IPF and surroundings: treatment update
12.00 - 13.00
VII SESSION: Focus on Centers
Chairperson: E. Barisione
Heidelberg ThoraxKlinik
Forlì Morgagni Hospital
Ancona Torrette Hospital
14.00 - 15.00
VIII SESSION: Guidelines/Statements
Chairperson: G. Failla
ERS guidelines
American guidelines/statements
WABIP point of view
15.00 - 16.00
IX SESSION: Lectures
Chairperson: E. Bendstrup
Lectio Magistralis: IPF pathogenesis
COVID-19 related lung fibrosis: is it a reality?